Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing ...
STOCKHOLM, SE / ACCESS Newswire / December 19, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs) ...
Neuraworx Medical Technology, Inc., a neurotechnology company developing first-in-class bioelectronic solutions for brain ...
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026Capital ...
Sermo Barometer reveals shifting access pathways, evolving prescribing behavior, and long-term impacts on patient care.NEW ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...
Athletic trainers can document treatments with the sam® wearable ultrasound device from ZetrOZ Systems to spotlight their ...
Sobi agrees to buy Arthrosi Therapeutics for up to $1.5 billion, adding the Phase 3 gout asset pozdeutinurad to expand its ...
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has ...
Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...
Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, and Expert Systems, a pioneer in next-generation AI solutions, today ...
The "Rare Diseases Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.The rare diseases treatment market is entering a pivotal phase marked by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback